$QTEX Cashflow Statement | Understand Stock

$QTEX

$1.37 +$0.02 (1.48%) Close

$QTEX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flow

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss
Depreciation
Share based compensation
Revaluation of financial liabilities accounted at fair value
Changes of financial liabilities - IPO non-cash expenses
Change in connection to loan from the Israeli Innovation Authority
Financial expenses
Decrease (increase) in other current assets
Increase (decrease) in trade accounts payables
Increase in other accounts payable
Net cash used in operating activities
Purchase of property, plant, and equipment
Payment of deposit
Change of deposit
Net cash used in investing activities
Principal paid on lease liabilities
Receipt of simple agreements for future equity (SAFE) and convertible loan
Receipt of IPO funds
Receipt of warrants exercise funds, net from fees
Loan from the Israeli Innovation Authority
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
Effects of exchange rate changes on cash and cash equivalents
Cash and cash equivalents at the end of the period
Tradable warrants at the IPO date
Tradable warrants financial liability at the IPO date
Share based compensation – underwriters fees at the IPO date
Warrants exercise to equity – financial liability
Warrants exercise – allocation from liability to equity
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation
Capital loss
Share based compensation expenses
Share based compensation – placement agent warrants
Revaluation of simple agreements for future equity (SAFE) and convertible loan at fair value
Evaluation of financial liability at fair value
Expiration of financial liability
Issuance cost
Issuance of ordinary shares - advisor fees
Prepayments of lease liabilities
Decrease (increase) in right of use assets, net
Decrease (increase) in other current assets
(Decrease) increase in trade accounts payables
(Decrease) increase in other accounts payable
(Increase) decrease in inventory
Unrealized foreign exchange (gain) loss
Financial expenses due to commitment fee – Standby Equity Purchase Agreement (SEPA)
Issuance of ordinary shares - commitment fee (SEPA)
Net cash used in operating activities

CASH FLOW FROM INVESTING ACTIVITIES:
Purchase of property, plant, and equipment
Investment in short term deposits
Proceeds from sale of short-term deposits
Change in deposits, net
Net cash provided by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Receipt of simple agreements for future equity (SAFE) and convertible loan
Issuance of ordinary shares, pre-funded warrants and ordinary warrants, net
Issuance cost in cash
Exercise of options
Issuance of ordinary shares (issuances pursuant to ATM)
Exercise of warrants and pre-funded warrants, net
Issuance of ordinary shares (issuances pursuant to an at-the-market facility), net
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Conversion of convertible loans to equity
Tradable warrants financial liability at IPO
Share based compensation – underwriters fees at IPO
Cash and cash equivalents
Restricted cash
Total cash, cash equivalents and restricted cash shown in the statement of cash flows
Other receivable in connection to December private placement
Accrued issuance expenses
Financial liability- placement agent fee (Note 10-A)
Share based compensation- placement agent warrants against additional paid in capital (Note 11)
Total non cash transactions
Interest paid

Comments